Skip to main content
. 2022 Nov 3;6(4):e354–e364. doi: 10.1055/s-0042-1757744

Table 8. Follow-up time by treatment.

Follow-up (days) VKA ( N  = 3,043) DOAC ( N  = 4,991) Total ( N  = 8,034)
Mean (SD) 257.4 (122.7) 252.7 (123.9) 254.5 (123.4)
Median (Q1,Q3) 355.0 (176.0, 365.0) 344.0 (141.5, 365.0) 346.0 (157.0, 365.0)
Min–Max 1.0–365.0 1.0–365.0 1.0–365.0
Missing 0 0 0

Abbreviations: DOAC, direct oral anticoagulants; VKA, vitamin K antagonist.